J Am Pharm Assoc (2003)
July 2025
Background: Immunosuppressive therapies are essential for transplant recipients and are increasingly prescribed in autoimmune and oncologic conditions. In France, community pharmacists are legally involved in Therapeutic Patient Education (TPE) and medication counseling. However, their level of knowledge regarding immunosuppressive therapies remains poorly documented.
View Article and Find Full Text PDFEur J Clin Microbiol Infect Dis
May 2025
Purpose: Obese patients treated with daptomycin at 4 mg/kg have a 30% increased drug exposure, potentially raising the risk of adverse events (AEs) like rhabdomyolysis. Given limited data on the safety of higher doses (10 mg/kg) in this population, this study aimed to assess the safety of high-dose daptomycin in obese patients and to identify potential AEs risk factors.
Methods: This multicenter, retrospective observational study was conducted from June 2021 to May 2022 using medical records.
Context: Poor medication management can lead to adverse outcomes for transplant patients, including acute rejection and graft loss. In recent years, mobile applications have been proposed as innovative tools to improve patient treatment management.
Objective: This review aimed to systematically evaluate the available research evidence on the relationship between mobile applications and treatment management in transplant patients.
Eur J Hosp Pharm
August 2025
Objectives: Therapeutic patient education (TPE) plays a critical role in the management of kidney transplant recipients. However, discrepancies exist in the guidance provided regarding the usage of immunosuppressants across different kidney transplant centres in France.
Methods: To assess the current landscape of TPE practices in this patient population, an online questionnaire consisting of 51 questions was distributed to 32 French renal transplantation centres.